The short version
Just 2 companies supply this market — thin enough that a single exit would be felt immediately.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Lorazepam
Lorazepam · LORAZEPAM 2 mg/mL · Liquid · Oral · American Health Packaging
NDC 68000-0108-05 · 50 SYRINGE in 1 CARTON / .5 mL in 1 SYRINGE · ANDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
90-day shortage risk (model v2)
0.1%chance of a new FDA shortage posting for lorazepam (other) in the next 90 days
sole-source market · price up 7% YoY
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Regulatory
- Application
- ANDA090260
- TE code
- AA
- Approval date
- Jun 15, 2010
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Lorazepam (Liquid)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Pharmaceutical Associates, Inc. | LORAZEPAM 2 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| American Health Packaging | LORAZEPAM 2 mg/mL | Aug 13, 2026 | Aug 31, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Lorazepam — NDC 68000-0108-05," retrieved September 3, 2026, https://drugdashboards.com/drug/68000010805.
Free to cite with attribution — see how the data is put together.